Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin-C vs Melphalan in CRS-HIPEC for Colorectal Peritoneal Carcinomatosis
NCT03073694Phase 2Unknown
- Sponsor
- University of Kansas Medical Center
- Start
- Jul 2017
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in colorectal cancer (CRC), appendiceal cancer, sponsored by University of Kansas Medical Center. Status: unknown.
02
Drugs
melphalan
03
Conditions
colorectal cancer (CRC)appendiceal cancer
Beyond the preview
Go deeper on NCT03073694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073694.